Genetic Analysis: Reagent kit sales soared 135% in Q2 2024, fueling growth and supporting US expansion

About this update from Genetic Analysis As

Reagent kit sales surged 135% year-over-year in Q2 2024, driving recurring revenue growth, while cost reductions improved net loss. Recent equity and loan financing support US expansion amid strong market demand for microbiome diagnostics.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Genetic Analysis As